CACNA1C rs3811801: Understanding Genetic Links to Mood Disorders
The rs3811801 variant is a single-nucleotide polymorphism located within the CACNA1C gene. Large-scale genome-wide association studies have linked this genetic region to an increased risk for psychiatric conditions, including bipolar disorder and major depressive disorder.
What each genotype means
Typical genetic risk profile
This genotype represents the homozygous state for the major allele at this position. Large-scale genome-wide association studies have linked variations in the CACNA1C gene to an increased risk of bipolar disorder and major depressive disorder, but this specific genotype is generally considered the baseline in the context of these studies. Genetic risk is polygenic, meaning many factors contribute to overall health, and this result should not be used to predict or diagnose any psychiatric condition.
This is the most common genotype in populations of European ancestry.
Increased risk association
This genotype includes one copy of the minor allele associated with psychiatric risk in large-scale genome-wide association studies. Research indicates that variants in the CACNA1C gene, which encodes a calcium channel subunit, are associated with a slightly higher statistical risk for bipolar disorder and major depressive disorder. This association is based on population-level data and does not imply that an individual will develop these conditions, as many environmental and genetic factors are involved.
This genotype is carried by a significant portion of the population, consistent with a minor allele frequency of approximately 0.20–0.30 in European ancestry groups.
Elevated risk association
This genotype is homozygous for the minor allele that has been identified in genome-wide association studies as having a statistical link to bipolar disorder and major depressive disorder. While this variant is associated with these conditions, it is a common genetic finding and is not a diagnostic marker for any psychiatric illness. Because psychiatric health is influenced by a complex interplay of many genes and environmental factors, this information should be viewed as a small part of a much larger picture.
This genotype is less common than the heterozygous or major-homozygous states, occurring in a smaller percentage of individuals of European ancestry.
What is rs3811801?
The rs3811801 variant is a specific genetic marker known as a single-nucleotide polymorphism (SNP). It is located within the CACNA1C gene, which provides instructions for building a critical component of calcium channels in the body. In genetics, an intronic variant like rs3811801 sits within a non-coding region of the gene, meaning it does not directly change the protein sequence itself. Instead, such variants are often studied for their potential to influence how much of a protein is produced or when it is expressed in specific tissues. Because this SNP is frequently identified in large-scale genetic studies, researchers use it as a signpost to investigate the complex biological pathways that may contribute to human health and disease. It is important to note that identifying a SNP does not mean it is the sole cause of a trait; rather, it is one of many genetic factors that researchers analyze to understand the architecture of complex human conditions.
The Role of the CACNA1C Gene
The CACNA1C gene is essential for the proper function of the nervous system and the heart. It encodes the Cav1.2 subunit, which is a primary component of L-type voltage-gated calcium channels. These channels act as gateways that allow calcium ions to flow into cells, a process that is fundamental to cellular signaling. In the brain, this calcium influx is vital for neuronal communication, the survival of hippocampal neurons, and the regulation of synaptic plasticity—the ability of synapses to strengthen or weaken over time. Because these channels are so central to how neurons fire and communicate, variations in the CACNA1C gene have been a major focus in psychiatric genetics. When these channels do not function optimally, it may affect how brain circuits process information, which is why researchers have spent decades investigating how specific variants in this gene might influence susceptibility to various neuropsychiatric syndromes.
Research and Evidence Strength
The association between CACNA1C and psychiatric disorders is well-documented in the scientific literature, particularly through genome-wide association studies (GWAS). These studies compare the genomes of thousands of individuals to identify common variants that appear more frequently in people with specific conditions. Research has consistently linked variants in the CACNA1C region to bipolar disorder, major depressive disorder, and schizophrenia. However, the evidence for any single SNP, such as rs3811801, is often described as having limited or moderate effect sizes. This means that while the variant is statistically associated with a higher risk, it is not a diagnostic tool and does not guarantee that an individual will develop a condition. Psychiatric traits are polygenic, meaning they are influenced by the cumulative effect of thousands of small genetic variations combined with environmental and lifestyle factors. Consequently, the clinical utility of this specific SNP remains a subject of ongoing scientific investigation.
Understanding Your Results
If you have received information about your genotype for rs3811801, it is important to view it within the context of current scientific understanding. This variant is a common genetic feature, and its presence does not constitute a medical diagnosis. Because psychiatric conditions are complex and influenced by a wide array of genetic and non-genetic factors, a single SNP cannot predict an individual's mental health outcomes. You cannot use this information to make medical decisions, such as starting, stopping, or changing medications. If you have concerns about your mental health or are interested in how your genetic background might relate to your well-being, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your health history and discuss any necessary clinical evaluations or support options that are tailored to your specific needs.
How common is this variant?
The rs3811801 variant is common, with a minor allele frequency (MAF) typically ranging between 0.20 and 0.30 in populations of European ancestry.
Frequently asked questions
Does having the rs3811801 variant mean I will develop bipolar disorder?
No. This variant is only one of many genetic factors associated with a slightly increased statistical risk. Most people who carry this variant will never develop bipolar disorder, as it is a complex condition influenced by many genes and environmental factors.
Can I use this SNP to predict my risk for depression?
Genetic testing for this SNP cannot be used to predict individual risk for depression. While the variant is linked to the condition in large population studies, it does not have enough predictive power to be used as a diagnostic or screening tool for individuals.
What should I do if I am worried about my mental health?
If you are concerned about your mental health, please reach out to a licensed mental health professional or your primary care physician. They can provide a comprehensive assessment and discuss evidence-based treatments that are appropriate for your specific situation.
Is this variant related to how medications work?
While CACNA1C is involved in calcium channel function, there is no established clinical guideline linking rs3811801 to specific medication responses. Always discuss any questions regarding your medications or treatment plans with your prescribing clinician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3811801?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CACNA1C
Intronic CACNA1C variant associated with subjective sleep latency and perceived sleep quality alterations.
An intronic regulatory variant within CACNA1C associated with differences in subjective sleep quality and sleep latency.
L-type calcium channel alpha-1C subunit intron variant associated with altered corticolimbic reactivity during emotional stress processing.
An intronic CACNA1C polymorphism linked to prolonged sleep onset latency and subjective sleep quality impairment.